- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 34.89M sh |
| Long Term Debt | Q1 2025 · Mar 28, 2025 | $1.24B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $980.15M |
| Short Term Debt | Q1 2025 · Mar 28, 2025 | $11K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $10M |
| Cash And Equivalents | Q1 2025 · Mar 28, 2025 | $31.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.54M |
| Current Liabilities | Q1 2025 · Mar 28, 2025 | $206.4M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $227.17M |
| Total Liabilities | Q1 2025 · Mar 28, 2025 | $1.69B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.46B |
| Current Assets | Q1 2025 · Mar 28, 2025 | $702.2M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $671.12M |
| Total Assets | Q1 2025 · Mar 28, 2025 | $3.3B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.08B |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 34.99M sh |
| Capex | Q1 2025 · Mar 29, 2024 | $29.07M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | $23.24M |
| Stockholders Equity | Q1 2025 · Mar 29, 2024 | $1.53B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.52B |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | $0.59 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | $0.61 |
| Sga Expense restated | Q1 2025 · Mar 29, 2024 | $46.44M |
| Net Income | Q1 2025 · Mar 29, 2024 | $20.51M |
| Operating Income restated | Q1 2025 · Mar 29, 2024 | $38.7M |
| Gross Profit restated | Q1 2025 · Mar 29, 2024 | $108.27M |
| Cost Of Revenue restated | Q1 2025 · Mar 29, 2024 | $299.52M |
| Revenue restated | Q1 2025 · Mar 29, 2024 | $407.8M |